Steven Gilman - Jun 3, 2022 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for Steven C. Gilman
Stock symbol
AKBA
Transactions as of
Jun 3, 2022
Transactions value $
-$1,653
Form type
4
Date filed
6/7/2022, 04:03 PM
Previous filing
May 18, 2022
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$1.65K -4.57K -9.52% $0.36 43.4K Jun 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 2, 2021.